Abstract The direct lineage reprogramming of somatic cells to other lineages by defined factors has led to innovative cell-fate-change approaches for providing patient-specific cells. Recent reports have demonstrated that four pluripotency factors (Oct4, Sox2, Klf4, and c-Myc) are sufficient to directly reprogram fibroblasts to other specific cells, including induced neural stem cells (iNSCs). Here, we show that mouse fibroblasts can be directly reprogrammed into midbrain dopaminergic neuronal progenitors (DPs) by temporal expression of the pluripotency factors and environment containing sonic hedgehog and fibroblast growth factor 8. Within thirteen days, self-renewing and functional induced DPs (iDPs) were generated. Interestingly, the inhibition of both Jak and Gsk3β notably enhanced the iDP reprogramming efficiency. We confirmed the functionality of the iDPs by showing that the dopaminergic neurons generated from iDPs express midbrain markers, release dopamine, and show typical electrophysiological profiles. Our results demonstrate that the pluripotency factors-mediated direct reprogramming is an invaluable strategy for supplying functional and proliferating iDPs and may be useful for other neural progenitors required for disease modeling and cell therapies for neurodegenerative disorders.
Introduction
Induced pluripotent stem cells (iPSCs) and cellular reprogramming technology (Takahashi et al., 2007; Takahashi and Yamanaka, 2006) provide tremendous potential in disease modeling, cell therapy, and regenerative medicine, likely leading to a personalized approach. Recent advances have shown that the fate of a cell type can be directly changed from one lineage to another by direct reprogramming using pre-determined reprogramming factors without generating pluripotent cells (Sancho-Martinez et al., 2012; Liu et al., 2012a) . The directly reprogrammed cells exhibit equivalent functionality to the differentiated cells from pluripotent cells and their in vivo counterparts and also show no tumorigenicity when they are transplanted in vivo (Liu et al., 2012a; Matsui et al., 2012) .
Most direct lineage reprogramming strategies use factors that show specific expression in target cells. In contrast, the pluripotency factor-mediated direct reprogramming (PDR) strategy uses the same pluripotency factors as iPSC reprogramming. During PDR, flexible intermediate cell types are generated, and those intermediates can be further specified into various tissue-specific target cells under specific conditions (Kim et al., 2011a Efe et al., 2011 ).
Parkinson's disease (PD) is a neurological disorder characterized by the degeneration of dopaminergic neurons in the midbrain substantia nigra, leading to a reduction of dopamine in the striatum (Gaillard and Jaber, 2011) . Currently, dopaminergic neurons can be obtained through differentiation from pluripotent cells (Ganat et al., 2012) . Recently, the direct conversion of fibroblasts also generates personalized induced dopaminergic neurons (Pfisterer et al., 2011; Caiazzo et al., 2011; Liu et al., 2012b; Kim et al., 2011b) . However, the terminally differentiated induced neurons are not adequate for transplantation (Rhee et al., 2011) . Progenitors or precursors should be advantageous in handling and obtaining the cells in vitro as well as in proper integration in vivo.
Thus, we hypothesized that dopaminergic progenitors/ precursors (DPs) also can be generated by direct lineage reprogramming. As the PDR approach can generate proliferating neural stem cells (NSCs) under appropriate environmental conditions (Liu et al., 2012a; Kim et al., 2011a; Wang et al., 2012; Thier et al., 2012; Han et al., 2012; Lu et al., 2013) , we assumed that DPs, which are further specified than general NSCs but not fully differentiated into neurons, can be generated under appropriately modified environmental conditions by PDR. Here, we showed that mouse fibroblasts can be directly reprogrammed into midbrainspecific DPs through the transient expression of the four Yamanaka factors under dopaminergic neuron-specific and intermediate cell-enriching conditions. This work demonstrates direct cell fate alteration from fibroblast to specific neural progenitors through PDR strategy and provides another novel route for obtaining useful progenitors for potential therapies and studies on various neural diseases.
Materials and methods

Direct reprogramming and differentiation
Reprogrammable MEFs were prepared as previously described (Kim et al., 2011a) and used for direct reprogramming into dopaminergic progenitors. The cells were plated on Matrigel-coated culture dishes at 2 × 10 4 cells/cm 2 in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS, 1% nonessential amino acids (NEAA), and 1% penicillin/ streptomycin. On the next day (D1), the cells were cultured in reprogramming initiation medium containing 10% knockout serum replacer, 5% FBS, 1% NEAA, 2 mM Glutamax, and 0.055 mM β-mercaptoethanol in knock-out DMEM for 4 days. Doxycycline (Dox) (Sigma, St. Louis, MO, USA) was included in media from the first day (D0) to day five (D5). For reprogramming to iDPs, the medium was changed to RepM-DP containing 1 × N2, 1 × B27, 0.05% BSA, 2 mM Glutamax, 0.11 mM β-mercaptoethanol, 200 ng/mL SHH (Peprotech, Rocky Hill, NJ, USA), and 100 ng/mL FGF8b (Peprotech) in advanced DMEM/F12 and neurobasal medium (1:1 mix) for the next 8 days. For reprogramming to iNSCs, the cells were cultured in RepM-Neural, as previously reported (Kim et al., 2011a) . For neuronal differentiation, NSC-like colonies were selected and dissociated into single cells with Accutase (Millipore, Billerica, MA, USA) and plated on poly-ornithine/laminin-coated culture dishes in differentiation medium containing 1 × N2, 1 × B27, 1.0 mM Glutamax, 0.11 mM β-mercaptoethanol, 1.0 mM dibutyrylcAMP (Enzo), 0.2 mM ascorbic acid (Sigma), 10 ng/mL brainderived neurotrophic factor (BDNF) (Peprotech), and 10 ng/mL glial cell line-derived neurotrophic factor (GDNF) (Peprotech) in DMEM/F12. The medium was changed every 3-4 days. Unless otherwise indicated, all reagents were purchased from Invitrogen (Carlsbad, CA, USA).
Quantitative RT-PCR
Total RNA was extracted from cultured cells using Trizol reagent (Invitrogen). cDNA was synthesized from 1 μg of total RNA using the SuperScript III Reverse Transcriptase Kit (Invitrogen) and oligo(dT) primers (Invitrogen) according to the manufacturer's instructions. Quantitative polymerase chain reaction (PCR) was performed with Power SYBR Green Master Mix (Takara Bio Inc., Shiga, Japan) and analyzed using the 7500 Fast Real-Time PCR system (Applied Biosystems). The primers used are listed in supplementary material Table S2 .
Immunocytochemistry
The cultured cells were immersed in 4% formaldehyde (Electron Microscopy Sciences, Ft. Washington, PA, USA) in PBS for 10 min and washed with PBS four times. The fixed cells were blocked and permeabilized with 0.3% Triton X-100, 10% FBS, and 1% BSA in PBS for 1 h at room temperature. After washing with PBS three times, the cells were incubated with primary antibody in blocking solution (PBS containing 10% FBS and 1% BSA) for 1 h. The primary antibodies are listed in supplementary material Table S3 . After the primary antibody reaction, the cells were washed with PBS three times and incubated for 1 h at room temperature in PBS containing 1% BSA with antimouse Alexa 488-conjugated (1:500, Invitrogen), anti-mouse Alexa 546-conjugated (1:500, Invitrogen), anti-rabbit Alexa 488-conjugated (1:500, Invitrogen), or anti-rabbit Alexa 546-conjugated (1:500, Invitrogen) secondary antibodies. Fluorescent images were obtained using an Axio Vert.A1 microscope (Carl Zeiss, Oberkochen, Germany).
Dopamine enzyme-linked immunosorbent assay
After 14 days of differentiation into dopaminergic neurons from neural precursor cells, the examination of dopamine release was performed as previously described (Trzaska et al., 2007) . Briefly, cells plated on a 24 well dish were washed with PBS then incubated in 200 μL of a low-KCl (4.5 mM) solution or 200 μL of a high-KCl (56 mM) solution for 10 min. Levels of dopamine in supernatants were quantified by using an enzyme-linked immunosorbent assay kit obtained from Rocky Mountain Diagnostics (Colorado, USA) according to the manufacturer's instructions.
Electrophysiology
The method of whole-cell patch-clamp recording has been described previously (Jung et al., 2012) . Cells plated on coverslips were placed in a submerged recording chamber and constantly perfused with oxygenated (95% O 2 , 5% CO 2 ), artificial cerebrospinal fluid (ACSF, 124 mM NaCl, 3.0 mM KCl, 1.23 mM NaH 2 PO 4 , 2.2 mM CaCl 2 , 1.2 mM MgCl 2 , 26 mM NaHCO 3 , and 10 mM glucose, pH 7.4). Whole-cell recordings were performed at 31°C using glass pipette electrodes (3-5 MΩ). To measure action potentials (APs), glass pipettes were filled with an internal solution (135 mM K-gluconate, 5 mM KCl, 2 mM MgCl 2 , 5 mM EGTA, 10 mM HEPES, 0.5 mM CaCl 2 , 5 mM Mg-ATP, and 0.3 mM Na-GTP) which was buffered to pH 7.4 with KOH. Resting membrane potential was estimated immediately after breaking the membrane and establishing a whole-cell configuration. APs were triggered by a step-current injection (10 pA steps) in current clamp mode for 500 ms. The threshold, amplitude, half-width, and after hyperpolarization (AHP) of the 1st AP were analyzed. Spontaneous firings were measured with 0 pA-current injection, and rebound APs were induced by brief injections of hyperpolarizing current (−20 pA). To block APs, 1 μM tetrodotoxin (TTX) was used. Patch-clamp recordings were performed using a MultiClamp 700B amplifier and a Digidata 1440 (Axon Instruments), and the acquired data were analyzed using the pCLAMP version 10.2 (Axon Instruments) and the Mini-Analysis Program (Synaptosoft) (Jung et al., 2012; Jeon et al., 2008) .
Lentivirus preparation and reprogramming mouse tail tip fibroblasts (TTFs)
Lentiviral infection was performed as described previously (Kim et al., 2011a) . Briefly, 293T cells were transfected with 8 μg pHAGE2-TetOminiCMV-STEMCCA or FUW-M2rtTA (Addgene) along with a packaging mixture (5 μg psPAX2 and 2.5 μg pMD2.G) (Addgene) and FuGENE HD transfection reagent (Promega, Madison, WI, USA) according to the manufacturer's instructions. TTF cells were prepared as previously described (Kim et al., 2011a) . After transduction with STEMCCA and rtTA-expressing virus, the cells were reprogrammed according to the procedure used for reprogrammable MEFs.
Statistical analysis
The results are presented as the mean ± s.e.m. Student's unpaired t-test was used for statistical evaluation, with p values of 0.01 or 0.001 as the level of significance.
Results and discussion Dopaminergic progenitors are directly reprogrammed from mouse fibroblasts During PDR, the lineage-specific commitment to target cells of interest is largely dependent on environmental cues (Liu et al., 2012a; Kim et al., 2011a Kim et al., , 2012 Efe et al., 2011) . Thus, to advance and expand the PDR approach to new target cell types, it is crucial to determine the appropriate environmental conditions. Accordingly, we attempted to determine which environmental factors were specifically required for direct reprogramming to DPs, as these factors were expected to be different from those to enable the reprogramming to iNSCs.
Similar to the direct reprogramming to iNSCs (Kim et al., 2011a) , the reprogrammable MEFs were used to induced dopaminergic progenitors/precursors (iDPs) to tightly control the expression of the four Yamanaka factors and enhance the homogeneity of the entire process. As a novel approach, we determined whether sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8), important morphogens for midbrain development that are generally used in differentiation to ventral midbrain dopaminergic neurons (Cho et al., 2008; Yan et al., 2005; Roussa and Krieglstein, 2004; Momcilovic et al., 2012; Swistowski et al., 2010) , possessed the potential to specify cell fate, particularly to DPs. At 5 days after Oct4, Sox2, Klf4, and c-Myc induction, the cells were further cultured in the presence of SHH and FGF8 (Fig. 1A) . Similar to the iNSC reprogramming in which FGF2, EGF, and FGF4 were used, under SHH-and FGF8-supplemented condition, colonies were emerged from around day 10 and grown continuously until the isolation on day 13 (Fig. 1B) . We compared these two approaches to investigate how the different environmental conditions affected the reprogramming. Surprisingly, the marker genes of ventral midbrain dopaminergic precursors, such as Pax2, Lmx1a, Msx1, Ngn2, Foxa2, and Corin (Rhee et al., 2011; Aguila et al., 2012; Roybon et al., 2008; Studer, 2012) , were initially detected from day 7, only two days after SHH and FGF8 supplementation, and distinctly increased compared to iNSC reprogramming ( Fig. 1C ; supplementary material Fig. S1 ). These results show that a highly specific and rapid cell fate change to DPs can be forced by the newly applied environmental factors SHH and FGF8 (SF) in our PDR approach.
To determine the properties of the reprogrammed cells with SHH and FGF8, we measured the amount of dopaminergic neurons differentiated from the reprogrammed iDPs and iNSCs under a serum-free differentiation condition. After 1-2 weeks of spontaneous differentiation, the reprogrammed iDPs yielded a higher proportion of TH + /TUJ1 + dopaminergic neurons (26.9 ± 7.2%) than iNSCs (b 3%) ( Fig. 1D and E ). These results demonstrate that the reprogrammed iDPs are significantly more potent than iNSCs in generating dopaminergic neurons. In summary, we were able to obtain iDPs with the PDR approach under the DP-favorable condition containing SHH and FGF8.
Inhibition of Jak and Gsk3β enhanced the reprogramming to iDPs
Although we could reprogram cells to iDPs, the efficiency of differentiation to TH + neurons from iDPs appeared to be comparable to the efficiency of differentiation from embryonic stem cells (ESCs) (Momcilovic et al., 2012) . Thus, to increase the efficiency of the process, we inhibited Jak-Stat signaling as in the PDR to induced cardiomyocytes, whereby a Jak-specific small molecule inhibitor increased the reprogramming efficiency (Efe et al., 2011 van Oosten et al., 2012; Yang et al., 2010) , would enrich the pool of intermediate cells which can be destined to iDPs by blocking the alternative path to the pluripotent state. As expected, temporal Jak inhibitor 1 (JI1) treatment from day 5 to day 7 significantly increased the expression of dopaminergic marker genes, such as En1, Lmx1a, FoxA2, and Corin, compared to untreated controls ( Fig. 2A) . Using immunocytochemistry, we also determined that En1-expressing cells were markedly increased in the JI1-treated iDP population (Fig. 2B) . Thus, we concluded that inhibition of Jak-Stat signaling in the intermediate cells is effective in enhancing the efficiency of direct reprogramming to iDPs. Second, we considered the contribution of Wnt signaling, which is important in the early (E9.5-E10.5) and late (E11.5-E12.5) stages of ventral midbrain dopaminergic neuronal development (Momcilovic et al., 2012; Prakash et al., 2006) and the differentiation of hESCs or iPSCs to dopaminergic neurons (Kirkeby et al., 2012; Kriks et al., 2011; Chung et al., 2009 ). We applied a specific inhibitor of Gsk3β, CT99021 (CT), to activate Wnt signaling and assessed with Corin expression, the most reliable marker of midbrain dopaminergic progenitors (Chung et al., 2011; Xi et al., 2012; Jonsson et al., 2009 ). We found an optimum time-frame and concentration of CT treatment to enhance the efficiency of reprogramming to iDPs ( Fig. 2C and D) . These results are similar to previous reports, in which both a specific concentration of CT and a particular time window of CT administration were necessary for specification to midbrain cells (Kirkeby et al., 2012; Xi et al., 2012) . Additionally, Corin-expressing cells were only detectable in the JI1-and CT-treated cultures on day 13 (supplementary material Fig. S2 ). In summary, we found that combined inhibition of Jak and Gsk3β significantly enhanced the process of DP specification during our direct reprogramming. In addition, the concentration and timewindow of CT treatment need to be finely optimized to obtain the highest reprogramming efficiency.
iDPs can self-renew and generate functional ventral midbrain dopaminergic neurons
After we optimized iDP generation (Fig. 3A) , we analyzed the characteristics of the dopaminergic neurons differentiated from the iDPs to prove the functionality of our reprogrammed iDPs. Most of the TH-expressing dopaminergic neurons costained with ventral midbrain precursor markers (FoxA2 and Lmx1a) and midbrain dopaminergic neuronal markers (Nurr1, En1, and Pitx3) (Studer, 2012) (Fig. 3B and supplementary  material Fig. S3A ), confirming that the differentiated dopaminergic neurons manifest midbrain specificity. We also showed that the JI1-treated iDPs generated 44.3 ± 8.4% TH + /TUJ1 + neurons and the JI1 and CT co-treated iDPs generated 57.2 ± 7.2% TH + /TUJ1 + neurons ( Fig. 3C ; supplementary material Fig. S3B ), confirming that the reprogramming efficiency to iDPs is actually increased by the combined treatment. To assess whether the generated TH-expressing neurons are functional dopaminergic neurons, we measured the level of released dopamine in the culture medium. As expected, the neurons from iDPs of higher reprogramming efficiency released even more dopamine than other samples (Fig. 3D ) and these dopamine releases were additionally increased by high-KCl solution (HK), a depolarizing condition. These results represent that the generated neurons from iDPs are functional dopaminergic neurons which show responsive release of dopamine. Finally, we analyzed the electrophysiological properties of the neurons from iDPs. Under a current-clamp configuration, depolarizing current injections with 10-pA steps induced action potentials (APs) in~42% of recorded cells (11/26 cells) (Fig. 3E) . The generation of APs were blocked by TTX treatment, indicating its dependency on voltage-gated sodium channels. A majority of cells (9/11 cells) showing APs also exhibited spontaneous firings (Fig. 3F ) and rebound depolarizations resulting in AP generation after short hyperpolarizations (Fig. 3G) , which are characteristics of midbrain dopamine neurons (Grace and Onn, 1989) . The electrophysiological properties of differentiated cells from iDPs were described in supplementary material Table S1 . We also tested whether the iDPs could self-renew in vitro. As previously reported (Chung et al., 2011) , under FGF2 containing culture condition, the Corin-expressing progenitors were increased (Fig. S4A) and showed co-expression with Ki67, a marker for proliferating cells (Fig. S4B) . The Corin-expressing population was maintained up to 16.22% by day 18 (Fig. S4C) . These results show that our directly reprogrammed iDPs are bona fide progenitors which can generate functional and responsive dopaminergic neurons of midbrain. Considering that catecholaminergic neurons also express TH, our direct reprogramming strategy to iDPs endorses a robust protocol for generating the midbrain-specific dopaminergic neurons which are required for potential cell therapy and drug discovery for PD.
Adult mouse tail tip fibroblasts are successfully reprogrammed into iDPs
Lastly, we evaluated our direct reprogramming to iDPs with mouse adult tail-tip fibroblasts (TTFs) using the Doxinducible STEMCCA system (Kim et al., 2011a; Sommer et al., 2009 ) to prove our reprogramming strategy is also effective with adult cells. As observed in iDPs from reprogrammable MEFs, we found highly efficient differentiation into TH-expressing neurons from TTF-iDPs compared to TTF-iNSCs ( Fig. 4A and B) . These TH-expressing neurons also expressed midbrain-specific markers, such as En1, FoxA2, and Pitx3 confirming the specification to midbrain DA neurons (Fig. 4C) . Thus, adult mouse fibroblasts can be efficiently reprogrammed into ventral midbrain iDPs by our PDR strategy.
Conclusions
Recently, several groups reported direct conversion of fibroblasts into dopaminergic neurons (Pfisterer et al., 2011; Caiazzo et al., 2011; Liu et al., 2012b; Kim et al., 2011b) , where the resulting cells are non-proliferating terminally differentiated neurons. We demonstrated here that mouse fibroblasts can be directly reprogrammed to functional and proliferating midbrain DPs through cell activation by pluripotency factors and directed specification by signal factors including SHH and FGF8. The trajectory of iDP reprogramming is traced as different from iNSC reprogramming. We were able to finely tune the process to increase the efficiency by co-inhibition of Jak and Gsk3β. The iDPs are functional and proliferating progenitors which give rise to typical midbrain dopaminergic neurons. We expect that our PDR strategy is not only applicable for iDP generation but also for direct lineage reprogramming to other progenitors which are required for various neural diseases.
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.scr.2013.09.007.
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